Hamill Laura

CIK 00017518047 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001751804

Recent Transactions

47 trades

Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−27,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−11,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Common Stock
2025-09-16−25,080→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−13,950→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−16,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−14,545→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−33,450→ 0 total
Disposition from Tender
Y-mAbs Therapeutics, Inc.
Common Stock
2025-09-16$8.60/sh−5,825→ 0 total
Tax Payment
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2025-08-08$111.25/sh−1,805→ 6,933 total
Award
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2025-08-07+3,507→ 8,738 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-06-30+33,450→ 33,450 total
Award
Y-mAbs Therapeutics, Inc.
Common Stock
2025-06-30+25,080→ 30,905 total
Award
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2024-08-02+3,731→ 5,231 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-06-11+14,545→ 14,545 total
Award
Y-mAbs Therapeutics, Inc.
Common Stock
2024-06-11+3,495→ 5,825 total
Disposition to Issuer
PARDES BIOSCIENCES, INC.
Stock Option (Right to Buy)
2023-08-31−37,500→ 0 total
Disposition to Issuer
PARDES BIOSCIENCES, INC.
Stock Option (Right to Buy)
2023-08-31−70,390→ 0 total
Disposition to Issuer
PARDES BIOSCIENCES, INC.
Stock Option (Right to Buy)
2023-08-31−75,000→ 0 total
Disposition to Issuer
PARDES BIOSCIENCES, INC.
Stock Option (Right to Buy)
2023-08-31−37,500→ 0 total
Award
Y-mAbs Therapeutics, Inc.
Common Stock
2023-06-08+2,330→ 2,330 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-06-08+13,950→ 13,950 total
Award
PARDES BIOSCIENCES, INC.
Stock Option (Right to Buy)
2023-06-01+37,500→ 37,500 total
Award
Scilex Holding Co$SCLX
Nonstatutory Stock Option (right to buy)
2023-01-17+250,000→ 250,000 total
Award
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2023-01-06+3,900→ 3,900 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2023-01-06+10,600→ 10,600 total
Award
Y-mAbs Therapeutics, Inc.
Non-Employee Stock Option (right to buy)
2022-07-15+16,000→ 16,000 total
Award
PARDES BIOSCIENCES, INC.
Stock Option (Right to Buy)
2022-06-08+37,500→ 37,500 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2022-02-10+9,200→ 9,200 total
Award
PARDES BIOSCIENCES, INC.
Stock Option (Right to Buy)
2021-12-23+75,000→ 75,000 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−941→ 0 total
Disposition from Tender
ACCELERON PHARMA INC
Common Stock
2021-11-19−474→ 0 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−9,339→ 0 total
Award
Y-mAbs Therapeutics, Inc.
Non-Employee Stock Option (right to buy)
2021-06-10+16,000→ 16,000 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2021-02-10+11,000→ 11,000 total
Award
ACCELERON PHARMA INC
Common Stock
2021-01-29+474→ 474 total
Award
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-01-29+941→ 941 total
Award
ACCELERON PHARMA INC
Option to Purchase Common Stock
2020-09-15+9,339→ 9,339 total
Award
Y-mAbs Therapeutics, Inc.
Non-Employee Stock Option (right to buy)
2020-06-23+32,000→ 32,000 total
Award
ANAPTYSBIO, INC$ANAB
Director Stock Option (Right to Buy)
2020-02-12+11,000→ 11,000 total
Award
ANAPTYSBIO, INC$ANAB
Director Stock Option (Rigth to Buy)
2019-09-24+6,000→ 6,000 total
Award
ANAPTYSBIO, INC$ANAB
Director Stock Option (Right to Buy)
2019-09-24+2,268→ 2,268 total
Award
GILEAD SCIENCES, INC.$GILD
Common Stock
2019-05-08+9,840→ 9,840 total
Tax Payment
GILEAD SCIENCES, INC.$GILD
Common Stock
2019-05-08$66.07/sh−3,500→ 6,340 total
Award
GILEAD SCIENCES, INC.$GILD
Restricted Stock Unit
2019-02-06+13,640→ 46,435 total
Award
GILEAD SCIENCES, INC.$GILD
Non-qualified Stock Option (Right to Buy)
2019-02-06+63,100→ 63,100 total
Award
GILEAD SCIENCES, INC.$GILD
Restricted Stock Unit
2018-10-07+32,795→ 32,795 total
Award
GILEAD SCIENCES, INC.$GILD
Non-qualified Stock Option (Right to Buy)
2018-10-07+87,680→ 87,680 total

Companies

Recent Filings

Address

C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE, SUITE 3350

NEW YORK, NY, 10169

View on SEC.gov